Biotix, Inc.
USPTO PatentsView assignee record - 76 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, Biotix ranks #4,605 of 49,997 tracked US assignees by granted-patent volume, with 76 patents across 5 technology areas.
- #4,605
- of 49,997 US assignees by volume
- 43rd percentile
- by Innovation Score (32.9/100)
- 11.3
- avg claims per patent
- +43%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4605 · US Corporation #4,605 · 76 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 76 grants
- TOP-DECILE #4,605/49,997
- PHOTO-FINISH Achillion Pharmaceut…
- CPC-NARROW B01L · 5 areas
- INNOV-THIN 32.9/100
- CLAIMS-PAR 11.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +43% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Achillion Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biotix’s 32.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biotix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Biotix · this assignee 33
Biotix · this assignee
33 score
- CardinalCommerce · near 33
CardinalCommerce · near
33 score
- Kyosan Denki · near 33
Kyosan Denki · near
33 score
- SonicSensory · near 33
SonicSensory · near
33 score
- Cosmax · near 33
Cosmax · near
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biotix's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biotix?
Each dot is one of Biotix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biotix’s own 11.3 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Biotix's grants concentrate
Biotix, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 60.5% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2020 (16 grants) versus a trough of 3 in 2024. By volume, Biotix sits between Achillion Pharmaceuticals, Inc. and Cascades Canada ULC.
Biotix's three-year grant acceleration
From 2019–2021 to 2022–2024, Biotix, Inc. moved from 35 to 17 grants (0.49x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Biotix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Achillion Pharmac…
Achillion Pharmaceuticals, Inc.
76 patents
- Aleddra
Aleddra Inc.
76 patents
- Aurrion
Aurrion, Inc.
76 patents
- Autonomous Soluti…
Autonomous Solutions, Inc.
76 patents
- Bioverativ Therap…
Bioverativ Therapeutics Inc.
76 patents
- Berkshire Grey
Berkshire Grey, Inc.
76 patents
- Bottomline
Bottomline Technologies, Inc.
76 patents
- Cascades Canada U…
Cascades Canada ULC
76 patents
- Biotix ◀
Biotix, Inc.
76 patents
What this shows Biotix holds 76 patents at rank #4,604, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biotix
By rank, the assignees closest to #4,604 in granted patent volume.
- Achillion Pharmaceuticals, Inc. #4,600 · 76 patents
- Aleddra Inc. #4,601 · 76 patents
- Aurrion, Inc. #4,602 · 76 patents
- Autonomous Solutions, Inc. #4,603 · 76 patents
- Bioverativ Therapeutics Inc. #4,605 · 76 patents
- Berkshire Grey, Inc. #4,606 · 76 patents
- Bottomline Technologies, Inc. #4,607 · 76 patents
- Cascades Canada ULC #4,608 · 76 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Biotix's primary technology class.
- The Regents of the University of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson and Company 193 in class
- Bio-Rad Laboratories, Inc. 174 in class
- President and Fellows of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Biotix, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Biotix ranks #35 of 1,325 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (33 here).
Similar claim depth
Nearest assignees by average claims per patent (11.3 here).
Biotix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 43rd percentile higher than 43% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 6.6% |
| 2016 | 4 | 5.3% |
| 2017 | 4 | 5.3% |
| 2018 | 8 | 10.5% |
| 2019 | 9 | 11.8% |
| 2020 | 16 | 21.1% |
| 2021 | 10 | 13.2% |
| 2022 | 8 | 10.5% |
| 2023 | 6 | 7.9% |
| 2024 | 3 | 3.9% |
| 2025partial year | 3 | 3.9% |
Which technologies does Biotix, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Biotix, Inc.'s patent record in context - here's where to go next.
- Biotix, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 60.5% of its portfolio - see every assignee active in that class. Explore B01L
- Ranked #4,605 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Biotix, Inc. against Achillion Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.